[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$tvtx](/topic/$tvtx)

### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$tvtx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$tvtx/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XXX% no change  
**6 Months**: XXX% no change  
**1-Year High**: XXX% on 2025-04-27  
**1-Year Low**: XX% on 2025-08-02  

**Most Supportive Themes**
- **FDA Approval/Positive News:** (45%) Positive sentiment surrounding the FDA's actions regarding the drug Filspari.
- **Analyst Upgrades and Price Target Increases:** (25%) Multiple analysts have upgraded Travere Therapeutics ($TVTX), increasing price targets and expressing positive outlooks.
- **Strong Performance and Momentum:** (20%) Posts highlight $TVTX as a top gainer, with significant price increases and mentions in various stock lists.
  
**Most Critical Themes**
- **Losses and Negative Sentiment:** (5%)  Some posts mention $TVTX as a loser or highlight negative aspects.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %  | Negative | %    |
| ------- | -------- | -  | ------- | -  | -------- | -    |
| X       | XX       | X% | XX      | X% |          |      |
|         |          |    |         |    |          |      |
| Total   | XX       | X% | XX      | X% | X        | NaN% |